nodes	percent_of_prediction	percent_of_DWPC	metapath
L-Glutamine—CTPS1—Synthesis and interconversion of nucleotide di- and triphosphates—NME1—peripheral nervous system neoplasm	0.0357	0.126	CbGpPWpGaD
L-Glutamine—TGM3—tongue—peripheral nervous system neoplasm	0.0202	0.0941	CbGeAlD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—LIN28B—peripheral nervous system neoplasm	0.0158	0.0556	CbGpPWpGaD
L-Glutamine—CAD—Endothelin Pathways—COX2—peripheral nervous system neoplasm	0.0122	0.0429	CbGpPWpGaD
L-Glutamine—CTPS1—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.0111	0.039	CbGpPWpGaD
L-Glutamine—GMPS—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00986	0.0347	CbGpPWpGaD
L-Glutamine—PFAS—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00986	0.0347	CbGpPWpGaD
L-Glutamine—SLC7A8—tongue—peripheral nervous system neoplasm	0.0089	0.0414	CbGeAlD
L-Glutamine—CCBL1—trigeminal ganglion—peripheral nervous system neoplasm	0.00843	0.0392	CbGeAlD
L-Glutamine—GMPS—trigeminal ganglion—peripheral nervous system neoplasm	0.0074	0.0344	CbGeAlD
L-Glutamine—GFPT2—trigeminal ganglion—peripheral nervous system neoplasm	0.00726	0.0338	CbGeAlD
L-Glutamine—PFAS—trigeminal ganglion—peripheral nervous system neoplasm	0.00726	0.0338	CbGeAlD
L-Glutamine—GLS—brainstem—peripheral nervous system neoplasm	0.00703	0.0327	CbGeAlD
L-Glutamine—GLUL—ganglion—peripheral nervous system neoplasm	0.007	0.0325	CbGeAlD
L-Glutamine—CTPS1—parotid gland—peripheral nervous system neoplasm	0.00697	0.0324	CbGeAlD
L-Glutamine—GFPT2—parotid gland—peripheral nervous system neoplasm	0.00685	0.0318	CbGeAlD
L-Glutamine—GMPS—brainstem—peripheral nervous system neoplasm	0.00654	0.0304	CbGeAlD
L-Glutamine—F13A1—trigeminal ganglion—peripheral nervous system neoplasm	0.00652	0.0303	CbGeAlD
L-Glutamine—F13A1—Formation of Fibrin Clot (Clotting Cascade)—KNG1—peripheral nervous system neoplasm	0.0065	0.0229	CbGpPWpGaD
L-Glutamine—CAD—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00635	0.0224	CbGpPWpGaD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—NME1—peripheral nervous system neoplasm	0.00629	0.0221	CbGpPWpGaD
L-Glutamine—QARS—trigeminal ganglion—peripheral nervous system neoplasm	0.00619	0.0288	CbGeAlD
L-Glutamine—F13A1—parotid gland—peripheral nervous system neoplasm	0.00615	0.0286	CbGeAlD
L-Glutamine—QARS—parotid gland—peripheral nervous system neoplasm	0.00584	0.0272	CbGeAlD
L-Glutamine—PPAT—Nucleotide metabolism—NME1—peripheral nervous system neoplasm	0.00581	0.0205	CbGpPWpGaD
L-Glutamine—CAD—trigeminal ganglion—peripheral nervous system neoplasm	0.00571	0.0266	CbGeAlD
L-Glutamine—CAD—parotid gland—peripheral nervous system neoplasm	0.00539	0.025	CbGeAlD
L-Glutamine—CAD—Endothelin Pathways—GNAS—peripheral nervous system neoplasm	0.00518	0.0183	CbGpPWpGaD
L-Glutamine—PPAT—parotid gland—peripheral nervous system neoplasm	0.005	0.0232	CbGeAlD
L-Glutamine—SLC1A5—trigeminal ganglion—peripheral nervous system neoplasm	0.00491	0.0228	CbGeAlD
L-Glutamine—SLC1A5—parotid gland—peripheral nervous system neoplasm	0.00463	0.0215	CbGeAlD
L-Glutamine—ASNS—trigeminal ganglion—peripheral nervous system neoplasm	0.00421	0.0196	CbGeAlD
L-Glutamine—NADSYN1—Defective AMN causes hereditary megaloblastic anemia 1—SLC2A1—peripheral nervous system neoplasm	0.00421	0.0148	CbGpPWpGaD
L-Glutamine—NADSYN1—cerebellum—peripheral nervous system neoplasm	0.00401	0.0186	CbGeAlD
L-Glutamine—GLS2—cerebellum—peripheral nervous system neoplasm	0.00401	0.0186	CbGeAlD
L-Glutamine—ASNS—parotid gland—peripheral nervous system neoplasm	0.00397	0.0185	CbGeAlD
L-Glutamine—GATB—cerebellum—peripheral nervous system neoplasm	0.00368	0.0171	CbGeAlD
L-Glutamine—CCBL1—cerebellum—peripheral nervous system neoplasm	0.00368	0.0171	CbGeAlD
L-Glutamine—GLS—cerebellum—peripheral nervous system neoplasm	0.00346	0.0161	CbGeAlD
L-Glutamine—GLUL—trigeminal ganglion—peripheral nervous system neoplasm	0.00344	0.016	CbGeAlD
L-Glutamine—F13A1—Platelet degranulation—KNG1—peripheral nervous system neoplasm	0.00343	0.0121	CbGpPWpGaD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—KNG1—peripheral nervous system neoplasm	0.00327	0.0115	CbGpPWpGaD
L-Glutamine—GLUL—parotid gland—peripheral nervous system neoplasm	0.00324	0.0151	CbGeAlD
L-Glutamine—CTPS1—cerebellum—peripheral nervous system neoplasm	0.00323	0.015	CbGeAlD
L-Glutamine—GMPS—cerebellum—peripheral nervous system neoplasm	0.00323	0.015	CbGeAlD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—SLC2A1—peripheral nervous system neoplasm	0.0032	0.0113	CbGpPWpGaD
L-Glutamine—PFAS—cerebellum—peripheral nervous system neoplasm	0.00317	0.0147	CbGeAlD
L-Glutamine—GFPT2—cerebellum—peripheral nervous system neoplasm	0.00317	0.0147	CbGeAlD
L-Glutamine—GLUL—brainstem—peripheral nervous system neoplasm	0.00304	0.0141	CbGeAlD
L-Glutamine—F13A1—Platelet degranulation—HGF—peripheral nervous system neoplasm	0.00286	0.0101	CbGpPWpGaD
L-Glutamine—F13A1—cerebellum—peripheral nervous system neoplasm	0.00284	0.0132	CbGeAlD
L-Glutamine—F13A1—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	0.00272	0.00959	CbGpPWpGaD
L-Glutamine—QARS—cerebellum—peripheral nervous system neoplasm	0.0027	0.0126	CbGeAlD
L-Glutamine—CAD—cerebellum—peripheral nervous system neoplasm	0.00249	0.0116	CbGeAlD
L-Glutamine—SLC16A10—parotid gland—peripheral nervous system neoplasm	0.00247	0.0115	CbGeAlD
L-Glutamine—PPAT—cerebellum—peripheral nervous system neoplasm	0.00231	0.0107	CbGeAlD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—BIRC5—peripheral nervous system neoplasm	0.00223	0.00787	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00215	0.00756	CbGpPWpGaD
L-Glutamine—SLC1A5—cerebellum—peripheral nervous system neoplasm	0.00214	0.00995	CbGeAlD
L-Glutamine—GLS2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00198	0.00698	CbGpPWpGaD
L-Glutamine—GLS—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00198	0.00698	CbGpPWpGaD
L-Glutamine—CCBL1—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00196	0.00689	CbGpPWpGaD
L-Glutamine—GLS—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00196	0.00689	CbGpPWpGaD
L-Glutamine—GLS2—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00196	0.00689	CbGpPWpGaD
L-Glutamine—SLC7A8—cerebellum—peripheral nervous system neoplasm	0.00193	0.00896	CbGeAlD
L-Glutamine—PFAS—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00191	0.00674	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00191	0.00674	CbGpPWpGaD
L-Glutamine—ASNS—cerebellum—peripheral nervous system neoplasm	0.00184	0.00854	CbGeAlD
L-Glutamine—NADSYN1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00175	0.00616	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—EED—peripheral nervous system neoplasm	0.00166	0.00585	CbGpPWpGaD
L-Glutamine—TGM2—Thromboxane A2 receptor signaling—AKT1—peripheral nervous system neoplasm	0.00159	0.00562	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00153	0.00539	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00153	0.00539	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00153	0.00539	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	0.00152	0.00536	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00152	0.00535	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.00152	0.00535	CbGpPWpGaD
L-Glutamine—PPAT—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.00151	0.00534	CbGpPWpGaD
L-Glutamine—GLUL—cerebellum—peripheral nervous system neoplasm	0.0015	0.00697	CbGeAlD
L-Glutamine—CTPS1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00145	0.00511	CbGpPWpGaD
L-Glutamine—SLC1A5—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00133	0.00468	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—SUZ12—peripheral nervous system neoplasm	0.00133	0.00468	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00129	0.00455	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00129	0.00455	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00128	0.00449	CbGpPWpGaD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	0.00127	0.00447	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00123	0.00434	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00118	0.00416	CbGpPWpGaD
L-Glutamine—SLC16A10—cerebellum—peripheral nervous system neoplasm	0.00114	0.00532	CbGeAlD
L-Glutamine—GLUL—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.00114	0.00401	CbGpPWpGaD
L-Glutamine—SLC38A3—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00113	0.00398	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00113	0.00397	CbGpPWpGaD
L-Glutamine—ASNS—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00112	0.00396	CbGpPWpGaD
L-Glutamine—GLUL—Amino acid and derivative metabolism—TH—peripheral nervous system neoplasm	0.00112	0.00396	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00108	0.00382	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—GNS—peripheral nervous system neoplasm	0.00105	0.00369	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00103	0.00364	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00103	0.00364	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.00103	0.00364	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—GNS—peripheral nervous system neoplasm	0.00102	0.00359	CbGpPWpGaD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—PTPN11—peripheral nervous system neoplasm	0.00101	0.00356	CbGpPWpGaD
L-Glutamine—Pain—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00201	CcSEcCtD
L-Glutamine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00101	0.00201	CcSEcCtD
L-Glutamine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00101	0.00201	CcSEcCtD
L-Glutamine—Injection site reaction—Doxorubicin—peripheral nervous system neoplasm	0.00101	0.00201	CcSEcCtD
L-Glutamine—Myalgia—Dactinomycin—peripheral nervous system neoplasm	0.001	0.00201	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—NME1—peripheral nervous system neoplasm	0.001	0.00354	CbGpPWpGaD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—MYC—peripheral nervous system neoplasm	0.001	0.00353	CbGpPWpGaD
L-Glutamine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.001	0.002	CcSEcCtD
L-Glutamine—Pain—Melphalan—peripheral nervous system neoplasm	0.000995	0.00198	CcSEcCtD
L-Glutamine—Discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000993	0.00198	CcSEcCtD
L-Glutamine—Malaise—Alitretinoin—peripheral nervous system neoplasm	0.000987	0.00197	CcSEcCtD
L-Glutamine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.000979	0.00195	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.000971	0.00194	CcSEcCtD
L-Glutamine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.000971	0.00194	CcSEcCtD
L-Glutamine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.000971	0.00194	CcSEcCtD
L-Glutamine—Urinary tract disorder—Etoposide—peripheral nervous system neoplasm	0.000969	0.00193	CcSEcCtD
L-Glutamine—Candida infection—Doxorubicin—peripheral nervous system neoplasm	0.000967	0.00193	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—COX2—peripheral nervous system neoplasm	0.000967	0.00341	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.000964	0.00192	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.000964	0.00192	CcSEcCtD
L-Glutamine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.000963	0.00192	CcSEcCtD
L-Glutamine—Urethral disorder—Etoposide—peripheral nervous system neoplasm	0.000962	0.00192	CcSEcCtD
L-Glutamine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.000957	0.00191	CcSEcCtD
L-Glutamine—Sepsis—Epirubicin—peripheral nervous system neoplasm	0.00095	0.0019	CcSEcCtD
L-Glutamine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.000939	0.00187	CcSEcCtD
L-Glutamine—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.000939	0.00187	CcSEcCtD
L-Glutamine—PFAS—Metabolism—GNS—peripheral nervous system neoplasm	0.000934	0.00329	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—GNS—peripheral nervous system neoplasm	0.000934	0.00329	CbGpPWpGaD
L-Glutamine—Malnutrition—Cisplatin—peripheral nervous system neoplasm	0.000932	0.00186	CcSEcCtD
L-Glutamine—Myalgia—Alitretinoin—peripheral nervous system neoplasm	0.000932	0.00186	CcSEcCtD
L-Glutamine—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000932	0.00186	CcSEcCtD
L-Glutamine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000932	0.00186	CcSEcCtD
L-Glutamine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000931	0.00186	CcSEcCtD
L-Glutamine—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.000931	0.00186	CcSEcCtD
L-Glutamine—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.000931	0.00186	CcSEcCtD
L-Glutamine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000931	0.00186	CcSEcCtD
L-Glutamine—Discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00092	0.00184	CcSEcCtD
L-Glutamine—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000919	0.00183	CcSEcCtD
L-Glutamine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.000911	0.00182	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.00091	0.00182	CcSEcCtD
L-Glutamine—Myalgia—Vincristine—peripheral nervous system neoplasm	0.000898	0.00179	CcSEcCtD
L-Glutamine—GMPS—Metabolism—NME1—peripheral nervous system neoplasm	0.000895	0.00315	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—NME1—peripheral nervous system neoplasm	0.000895	0.00315	CbGpPWpGaD
L-Glutamine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000893	0.00178	CcSEcCtD
L-Glutamine—CCBL1—Disease—GNS—peripheral nervous system neoplasm	0.000891	0.00314	CbGpPWpGaD
L-Glutamine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.00089	0.00178	CcSEcCtD
L-Glutamine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.000887	0.00177	CcSEcCtD
L-Glutamine—Chills—Etoposide—peripheral nervous system neoplasm	0.00088	0.00176	CcSEcCtD
L-Glutamine—Sepsis—Doxorubicin—peripheral nervous system neoplasm	0.000879	0.00175	CcSEcCtD
L-Glutamine—ASNS—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000878	0.00309	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000878	0.00309	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000877	0.00175	CcSEcCtD
L-Glutamine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000875	0.00175	CcSEcCtD
L-Glutamine—GLUL—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000872	0.00307	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000868	0.00173	CcSEcCtD
L-Glutamine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000868	0.00173	CcSEcCtD
L-Glutamine—Ill-defined disorder—Cisplatin—peripheral nervous system neoplasm	0.000865	0.00173	CcSEcCtD
L-Glutamine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000863	0.00172	CcSEcCtD
L-Glutamine—PFAS—Metabolism—COX2—peripheral nervous system neoplasm	0.000862	0.00304	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—COX2—peripheral nervous system neoplasm	0.000862	0.00304	CbGpPWpGaD
L-Glutamine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00086	0.00172	CcSEcCtD
L-Glutamine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000857	0.00171	CcSEcCtD
L-Glutamine—Infection—Vincristine—peripheral nervous system neoplasm	0.000855	0.00171	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—GNS—peripheral nervous system neoplasm	0.000854	0.00301	CbGpPWpGaD
L-Glutamine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000852	0.0017	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000846	0.00298	CbGpPWpGaD
L-Glutamine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000845	0.00169	CcSEcCtD
L-Glutamine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000845	0.00169	CcSEcCtD
L-Glutamine—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000842	0.00168	CcSEcCtD
L-Glutamine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.000841	0.00168	CcSEcCtD
L-Glutamine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00084	0.00168	CcSEcCtD
L-Glutamine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000834	0.00167	CcSEcCtD
L-Glutamine—SLC7A8—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000834	0.00294	CbGpPWpGaD
L-Glutamine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000834	0.00166	CcSEcCtD
L-Glutamine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000834	0.00166	CcSEcCtD
L-Glutamine—CAD—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000832	0.00293	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000832	0.00166	CcSEcCtD
L-Glutamine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00083	0.00166	CcSEcCtD
L-Glutamine—Back pain—Etoposide—peripheral nervous system neoplasm	0.000826	0.00165	CcSEcCtD
L-Glutamine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000824	0.00164	CcSEcCtD
L-Glutamine—CAD—Validated targets of C-MYC transcriptional activation—TP53—peripheral nervous system neoplasm	0.000824	0.0029	CbGpPWpGaD
L-Glutamine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000823	0.00164	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—NME1—peripheral nervous system neoplasm	0.000819	0.00289	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000814	0.00162	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—CASP3—peripheral nervous system neoplasm	0.00081	0.00285	CbGpPWpGaD
L-Glutamine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000808	0.00161	CcSEcCtD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000801	0.00282	CbGpPWpGaD
L-Glutamine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000794	0.00158	CcSEcCtD
L-Glutamine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000794	0.00158	CcSEcCtD
L-Glutamine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000792	0.00158	CcSEcCtD
L-Glutamine—GFPT2—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000789	0.00278	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—COX2—peripheral nervous system neoplasm	0.000788	0.00278	CbGpPWpGaD
L-Glutamine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000788	0.00157	CcSEcCtD
L-Glutamine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000785	0.00157	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000784	0.00276	CbGpPWpGaD
L-Glutamine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000784	0.00156	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000784	0.00156	CcSEcCtD
L-Glutamine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000779	0.00156	CcSEcCtD
L-Glutamine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000779	0.00156	CcSEcCtD
L-Glutamine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000778	0.00155	CcSEcCtD
L-Glutamine—Malaise—Etoposide—peripheral nervous system neoplasm	0.00077	0.00154	CcSEcCtD
L-Glutamine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00077	0.00154	CcSEcCtD
L-Glutamine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000764	0.00152	CcSEcCtD
L-Glutamine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000764	0.00152	CcSEcCtD
L-Glutamine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000761	0.00152	CcSEcCtD
L-Glutamine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000761	0.00152	CcSEcCtD
L-Glutamine—PPAT—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000761	0.00268	CbGpPWpGaD
L-Glutamine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000761	0.00152	CcSEcCtD
L-Glutamine—Infection—Cisplatin—peripheral nervous system neoplasm	0.000756	0.00151	CcSEcCtD
L-Glutamine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000755	0.00151	CcSEcCtD
L-Glutamine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000749	0.0015	CcSEcCtD
L-Glutamine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000749	0.0015	CcSEcCtD
L-Glutamine—Rash—Topotecan—peripheral nervous system neoplasm	0.000749	0.00149	CcSEcCtD
L-Glutamine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000748	0.00149	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—GNS—peripheral nervous system neoplasm	0.000747	0.00263	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GNS—peripheral nervous system neoplasm	0.000747	0.00263	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GNS—peripheral nervous system neoplasm	0.000747	0.00263	CbGpPWpGaD
L-Glutamine—Headache—Topotecan—peripheral nervous system neoplasm	0.000744	0.00149	CcSEcCtD
L-Glutamine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000743	0.00148	CcSEcCtD
L-Glutamine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000743	0.00148	CcSEcCtD
L-Glutamine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000742	0.00148	CcSEcCtD
L-Glutamine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000742	0.00148	CcSEcCtD
L-Glutamine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000742	0.00148	CcSEcCtD
L-Glutamine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000739	0.00148	CcSEcCtD
L-Glutamine—Dehydration—Epirubicin—peripheral nervous system neoplasm	0.000739	0.00148	CcSEcCtD
L-Glutamine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000738	0.00147	CcSEcCtD
L-Glutamine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000738	0.00147	CcSEcCtD
L-Glutamine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000736	0.00147	CcSEcCtD
L-Glutamine—Constipation—Vincristine—peripheral nervous system neoplasm	0.000736	0.00147	CcSEcCtD
L-Glutamine—Pain—Vincristine—peripheral nervous system neoplasm	0.000736	0.00147	CcSEcCtD
L-Glutamine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000736	0.00147	CcSEcCtD
L-Glutamine—Rash—Melphalan—peripheral nervous system neoplasm	0.000733	0.00146	CcSEcCtD
L-Glutamine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000733	0.00146	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00073	0.00146	CcSEcCtD
L-Glutamine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000727	0.00145	CcSEcCtD
L-Glutamine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000718	0.00143	CcSEcCtD
L-Glutamine—GLS2—Metabolism—NME1—peripheral nervous system neoplasm	0.000716	0.00252	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—NME1—peripheral nervous system neoplasm	0.000716	0.00252	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—NME1—peripheral nervous system neoplasm	0.000716	0.00252	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000713	0.00251	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00071	0.00142	CcSEcCtD
L-Glutamine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000706	0.00141	CcSEcCtD
L-Glutamine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000706	0.00141	CcSEcCtD
L-Glutamine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000706	0.00141	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000704	0.0014	CcSEcCtD
L-Glutamine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.0007	0.0014	CcSEcCtD
L-Glutamine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.0007	0.0014	CcSEcCtD
L-Glutamine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000693	0.00138	CcSEcCtD
L-Glutamine—Infection—Etoposide—peripheral nervous system neoplasm	0.000692	0.00138	CcSEcCtD
L-Glutamine—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.000692	0.00138	CcSEcCtD
L-Glutamine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000691	0.00138	CcSEcCtD
L-Glutamine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000691	0.00138	CcSEcCtD
L-Glutamine—GLS2—Metabolism—COX2—peripheral nervous system neoplasm	0.000689	0.00243	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—COX2—peripheral nervous system neoplasm	0.000689	0.00243	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—COX2—peripheral nervous system neoplasm	0.000689	0.00243	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000686	0.00242	CbGpPWpGaD
L-Glutamine—Dehydration—Doxorubicin—peripheral nervous system neoplasm	0.000684	0.00137	CcSEcCtD
L-Glutamine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00068	0.00136	CcSEcCtD
L-Glutamine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00068	0.00136	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—NRAS—peripheral nervous system neoplasm	0.000679	0.00239	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000675	0.00238	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000674	0.00134	CcSEcCtD
L-Glutamine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000674	0.00134	CcSEcCtD
L-Glutamine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000658	0.00131	CcSEcCtD
L-Glutamine—F13A1—Hemostasis—HGF—peripheral nervous system neoplasm	0.000653	0.0023	CbGpPWpGaD
L-Glutamine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000651	0.0013	CcSEcCtD
L-Glutamine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000641	0.00128	CcSEcCtD
L-Glutamine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.00064	0.00128	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000635	0.00224	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000634	0.00127	CcSEcCtD
L-Glutamine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000632	0.00126	CcSEcCtD
L-Glutamine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000627	0.00125	CcSEcCtD
L-Glutamine—CCBL1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000623	0.0022	CbGpPWpGaD
L-Glutamine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000623	0.00124	CcSEcCtD
L-Glutamine—NADSYN1—Disease—ENO2—peripheral nervous system neoplasm	0.000618	0.00218	CbGpPWpGaD
L-Glutamine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000617	0.00123	CcSEcCtD
L-Glutamine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000612	0.00122	CcSEcCtD
L-Glutamine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000607	0.00121	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—NRAS—peripheral nervous system neoplasm	0.000607	0.00214	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—GNS—peripheral nervous system neoplasm	0.000602	0.00212	CbGpPWpGaD
L-Glutamine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000601	0.0012	CcSEcCtD
L-Glutamine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000601	0.0012	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000601	0.0012	CcSEcCtD
L-Glutamine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000596	0.00119	CcSEcCtD
L-Glutamine—Pain—Etoposide—peripheral nervous system neoplasm	0.000596	0.00119	CcSEcCtD
L-Glutamine—ASNS—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000593	0.00209	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000593	0.00209	CbGpPWpGaD
L-Glutamine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000591	0.00118	CcSEcCtD
L-Glutamine—CAD—Metabolism—NME1—peripheral nervous system neoplasm	0.000577	0.00203	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000574	0.00115	CcSEcCtD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000574	0.00202	CbGpPWpGaD
L-Glutamine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000572	0.00114	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00057	0.00114	CcSEcCtD
L-Glutamine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000569	0.00114	CcSEcCtD
L-Glutamine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000568	0.00113	CcSEcCtD
L-Glutamine—GMPS—Metabolism—ENO2—peripheral nervous system neoplasm	0.000566	0.00199	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ENO2—peripheral nervous system neoplasm	0.000566	0.00199	CbGpPWpGaD
L-Glutamine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000563	0.00112	CcSEcCtD
L-Glutamine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000563	0.00112	CcSEcCtD
L-Glutamine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000561	0.00112	CcSEcCtD
L-Glutamine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000559	0.00112	CcSEcCtD
L-Glutamine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.00111	CcSEcCtD
L-Glutamine—CAD—Metabolism—COX2—peripheral nervous system neoplasm	0.000555	0.00196	CbGpPWpGaD
L-Glutamine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000551	0.0011	CcSEcCtD
L-Glutamine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000551	0.0011	CcSEcCtD
L-Glutamine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000551	0.0011	CcSEcCtD
L-Glutamine—PPAT—Metabolism—GNS—peripheral nervous system neoplasm	0.00055	0.00194	CbGpPWpGaD
L-Glutamine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000547	0.00109	CcSEcCtD
L-Glutamine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000546	0.00109	CcSEcCtD
L-Glutamine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000546	0.00109	CcSEcCtD
L-Glutamine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000543	0.00108	CcSEcCtD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000543	0.00191	CbGpPWpGaD
L-Glutamine—Rash—Vincristine—peripheral nervous system neoplasm	0.000543	0.00108	CcSEcCtD
L-Glutamine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000542	0.00108	CcSEcCtD
L-Glutamine—CCBL1—Disease—ENO2—peripheral nervous system neoplasm	0.00054	0.0019	CbGpPWpGaD
L-Glutamine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000539	0.00108	CcSEcCtD
L-Glutamine—Headache—Vincristine—peripheral nervous system neoplasm	0.000539	0.00108	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000536	0.00189	CbGpPWpGaD
L-Glutamine—SLC1A5—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000533	0.00188	CbGpPWpGaD
L-Glutamine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00053	0.00106	CcSEcCtD
L-Glutamine—PPAT—Metabolism—NME1—peripheral nervous system neoplasm	0.000528	0.00186	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000517	0.00182	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000514	0.00102	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000512	0.0018	CbGpPWpGaD
L-Glutamine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000511	0.00102	CcSEcCtD
L-Glutamine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.00051	0.00102	CcSEcCtD
L-Glutamine—PPAT—Metabolism—COX2—peripheral nervous system neoplasm	0.000508	0.00179	CbGpPWpGaD
L-Glutamine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000505	0.00101	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—TH—peripheral nervous system neoplasm	0.000504	0.00178	CbGpPWpGaD
L-Glutamine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000503	0.001	CcSEcCtD
L-Glutamine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.0005	0.000998	CcSEcCtD
L-Glutamine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000499	0.000996	CcSEcCtD
L-Glutamine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000499	0.000996	CcSEcCtD
L-Glutamine—NADSYN1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000498	0.00175	CbGpPWpGaD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—HRAS—peripheral nervous system neoplasm	0.000497	0.00175	CbGpPWpGaD
L-Glutamine—Chills—Epirubicin—peripheral nervous system neoplasm	0.000493	0.000985	CcSEcCtD
L-Glutamine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000493	0.000984	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000486	0.00171	CbGpPWpGaD
L-Glutamine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000484	0.000965	CcSEcCtD
L-Glutamine—SLC16A10—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000484	0.0017	CbGpPWpGaD
L-Glutamine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000482	0.000962	CcSEcCtD
L-Glutamine—Rash—Cisplatin—peripheral nervous system neoplasm	0.00048	0.000957	CcSEcCtD
L-Glutamine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000479	0.000957	CcSEcCtD
L-Glutamine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.000479	0.000955	CcSEcCtD
L-Glutamine—PFAS—Metabolism—BCHE—peripheral nervous system neoplasm	0.000478	0.00168	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—BCHE—peripheral nervous system neoplasm	0.000478	0.00168	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000477	0.00168	CbGpPWpGaD
L-Glutamine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000472	0.000941	CcSEcCtD
L-Glutamine—GLS—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000465	0.00164	CbGpPWpGaD
L-Glutamine—GLS2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000465	0.00164	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000464	0.00164	CbGpPWpGaD
L-Glutamine—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000463	0.000924	CcSEcCtD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000462	0.00163	CbGpPWpGaD
L-Glutamine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000921	CcSEcCtD
L-Glutamine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000461	0.00092	CcSEcCtD
L-Glutamine—Chills—Doxorubicin—peripheral nervous system neoplasm	0.000457	0.000911	CcSEcCtD
L-Glutamine—GMPS—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000456	0.00161	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000456	0.00161	CbGpPWpGaD
L-Glutamine—SLC38A3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000453	0.0016	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000452	0.00159	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—ENO2—peripheral nervous system neoplasm	0.000452	0.00159	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000452	0.00159	CbGpPWpGaD
L-Glutamine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000452	0.000902	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—KNG1—peripheral nervous system neoplasm	0.00045	0.00159	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—TH—peripheral nervous system neoplasm	0.000449	0.00158	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—TH—peripheral nervous system neoplasm	0.000449	0.00158	CbGpPWpGaD
L-Glutamine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000446	0.00089	CcSEcCtD
L-Glutamine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000444	0.000887	CcSEcCtD
L-Glutamine—SLC7A8—Cell surface interactions at the vascular wall—HRAS—peripheral nervous system neoplasm	0.000444	0.00156	CbGpPWpGaD
L-Glutamine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000443	0.000884	CcSEcCtD
L-Glutamine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.000443	0.000884	CcSEcCtD
L-Glutamine—Rash—Etoposide—peripheral nervous system neoplasm	0.00044	0.000877	CcSEcCtD
L-Glutamine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000439	0.000876	CcSEcCtD
L-Glutamine—GLUL—TNF alpha Signaling Pathway—AKT1—peripheral nervous system neoplasm	0.000439	0.00155	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000437	0.00154	CbGpPWpGaD
L-Glutamine—Headache—Etoposide—peripheral nervous system neoplasm	0.000437	0.000871	CcSEcCtD
L-Glutamine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000871	CcSEcCtD
L-Glutamine—CCBL1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000435	0.00153	CbGpPWpGaD
L-Glutamine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000432	0.000862	CcSEcCtD
L-Glutamine—ASNS—Metabolism—GNS—peripheral nervous system neoplasm	0.000429	0.00151	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GNS—peripheral nervous system neoplasm	0.000429	0.00151	CbGpPWpGaD
L-Glutamine—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000428	0.000855	CcSEcCtD
L-Glutamine—ASNS—Metabolism of proteins—BCHE—peripheral nervous system neoplasm	0.000426	0.0015	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000424	0.00149	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000417	0.00147	CbGpPWpGaD
L-Glutamine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000414	0.000826	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000412	0.00145	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—TH—peripheral nervous system neoplasm	0.000411	0.00145	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—NME1—peripheral nervous system neoplasm	0.000411	0.00145	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—NME1—peripheral nervous system neoplasm	0.000411	0.00145	CbGpPWpGaD
L-Glutamine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000411	0.00082	CcSEcCtD
L-Glutamine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000813	CcSEcCtD
L-Glutamine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000813	CcSEcCtD
L-Glutamine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000408	0.000813	CcSEcCtD
L-Glutamine—CTPS1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000404	0.00142	CbGpPWpGaD
L-Glutamine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000403	0.000804	CcSEcCtD
L-Glutamine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000399	0.000797	CcSEcCtD
L-Glutamine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000399	0.000796	CcSEcCtD
L-Glutamine—GLUL—Metabolism—COX2—peripheral nervous system neoplasm	0.000396	0.00139	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—COX2—peripheral nervous system neoplasm	0.000396	0.00139	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000394	0.00139	CbGpPWpGaD
L-Glutamine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000391	0.00078	CcSEcCtD
L-Glutamine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000388	0.000775	CcSEcCtD
L-Glutamine—CCBL1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000382	0.00135	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—BCHE—peripheral nervous system neoplasm	0.000382	0.00135	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—BCHE—peripheral nervous system neoplasm	0.000382	0.00135	CbGpPWpGaD
L-Glutamine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000754	CcSEcCtD
L-Glutamine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000753	CcSEcCtD
L-Glutamine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000753	CcSEcCtD
L-Glutamine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000377	0.000753	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—HGF—peripheral nervous system neoplasm	0.000375	0.00132	CbGpPWpGaD
L-Glutamine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000373	0.000744	CcSEcCtD
L-Glutamine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000736	CcSEcCtD
L-Glutamine—GMPS—Metabolism—GNAS—peripheral nervous system neoplasm	0.000367	0.00129	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—GNAS—peripheral nervous system neoplasm	0.000367	0.00129	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—ENO2—peripheral nervous system neoplasm	0.000365	0.00128	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000365	0.00128	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000365	0.00128	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000365	0.00128	CbGpPWpGaD
L-Glutamine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000722	CcSEcCtD
L-Glutamine—GMPS—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00036	0.00127	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—ABCB1—peripheral nervous system neoplasm	0.00036	0.00127	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—TH—peripheral nervous system neoplasm	0.000359	0.00127	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—TH—peripheral nervous system neoplasm	0.000359	0.00127	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—TH—peripheral nervous system neoplasm	0.000359	0.00127	CbGpPWpGaD
L-Glutamine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000359	0.000717	CcSEcCtD
L-Glutamine—F13A1—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	0.000359	0.00127	CbGpPWpGaD
L-Glutamine—GLS—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000356	0.00125	CbGpPWpGaD
L-Glutamine—GLS2—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000356	0.00125	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000356	0.00071	CcSEcCtD
L-Glutamine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000705	CcSEcCtD
L-Glutamine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000698	CcSEcCtD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000341	0.0012	CbGpPWpGaD
L-Glutamine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000337	0.000672	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000336	0.00118	CbGpPWpGaD
L-Glutamine—SLC7A8—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000335	0.00118	CbGpPWpGaD
L-Glutamine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000667	CcSEcCtD
L-Glutamine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000334	0.000667	CcSEcCtD
L-Glutamine—PPAT—Metabolism—ENO2—peripheral nervous system neoplasm	0.000333	0.00117	CbGpPWpGaD
L-Glutamine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000657	CcSEcCtD
L-Glutamine—NADSYN1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000329	0.00116	CbGpPWpGaD
L-Glutamine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000327	0.000653	CcSEcCtD
L-Glutamine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000322	0.000643	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00032	0.000638	CcSEcCtD
L-Glutamine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000312	0.000622	CcSEcCtD
L-Glutamine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000617	CcSEcCtD
L-Glutamine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000309	0.000617	CcSEcCtD
L-Glutamine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000616	CcSEcCtD
L-Glutamine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.000309	0.000616	CcSEcCtD
L-Glutamine—CAD—Metabolism—BCHE—peripheral nervous system neoplasm	0.000308	0.00109	CbGpPWpGaD
L-Glutamine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000298	0.000595	CcSEcCtD
L-Glutamine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000296	0.00059	CcSEcCtD
L-Glutamine—CAD—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000294	0.00104	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—GNAS—peripheral nervous system neoplasm	0.000293	0.00103	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—GNAS—peripheral nervous system neoplasm	0.000293	0.00103	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000293	0.00103	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—TH—peripheral nervous system neoplasm	0.00029	0.00102	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000288	0.000575	CcSEcCtD
L-Glutamine—GLS—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000288	0.00101	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000288	0.00101	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000288	0.00101	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000287	0.00101	CbGpPWpGaD
L-Glutamine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.00057	CcSEcCtD
L-Glutamine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.000286	0.00057	CcSEcCtD
L-Glutamine—PPAT—Metabolism—BCHE—peripheral nervous system neoplasm	0.000282	0.000993	CbGpPWpGaD
L-Glutamine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00028	0.000559	CcSEcCtD
L-Glutamine—NADSYN1—Disease—PTPN11—peripheral nervous system neoplasm	0.000278	0.000981	CbGpPWpGaD
L-Glutamine—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000552	CcSEcCtD
L-Glutamine—SLC7A8—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000274	0.000965	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000269	0.000947	CbGpPWpGaD
L-Glutamine—GLUL—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000267	0.00094	CbGpPWpGaD
L-Glutamine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000266	0.000532	CcSEcCtD
L-Glutamine—PPAT—Metabolism—TH—peripheral nervous system neoplasm	0.000265	0.000933	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ENO2—peripheral nervous system neoplasm	0.00026	0.000915	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ENO2—peripheral nervous system neoplasm	0.00026	0.000915	CbGpPWpGaD
L-Glutamine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000259	0.000518	CcSEcCtD
L-Glutamine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000258	0.000516	CcSEcCtD
L-Glutamine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.00051	CcSEcCtD
L-Glutamine—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000248	0.000496	CcSEcCtD
L-Glutamine—Rash—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000492	CcSEcCtD
L-Glutamine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000246	0.000491	CcSEcCtD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000246	0.000866	CbGpPWpGaD
L-Glutamine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000245	0.000489	CcSEcCtD
L-Glutamine—CCBL1—Disease—PTPN11—peripheral nervous system neoplasm	0.000243	0.000858	CbGpPWpGaD
L-Glutamine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000239	0.000477	CcSEcCtD
L-Glutamine—CAD—Metabolism—GNAS—peripheral nervous system neoplasm	0.000236	0.000833	CbGpPWpGaD
L-Glutamine—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000232	0.000463	CcSEcCtD
L-Glutamine—CAD—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000232	0.000817	CbGpPWpGaD
L-Glutamine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000459	CcSEcCtD
L-Glutamine—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000455	CcSEcCtD
L-Glutamine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000228	0.000455	CcSEcCtD
L-Glutamine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000226	0.000452	CcSEcCtD
L-Glutamine—NADSYN1—Disease—ERBB2—peripheral nervous system neoplasm	0.00022	0.000775	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—BCHE—peripheral nervous system neoplasm	0.00022	0.000773	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—BCHE—peripheral nervous system neoplasm	0.00022	0.000773	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—TP53—peripheral nervous system neoplasm	0.000219	0.000772	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—GNAS—peripheral nervous system neoplasm	0.000216	0.000762	CbGpPWpGaD
L-Glutamine—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000215	0.000429	CcSEcCtD
L-Glutamine—PPAT—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000212	0.000748	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—HRAS—peripheral nervous system neoplasm	0.00021	0.000739	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000209	0.000738	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000209	0.000738	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—TH—peripheral nervous system neoplasm	0.000206	0.000727	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—TH—peripheral nervous system neoplasm	0.000206	0.000727	CbGpPWpGaD
L-Glutamine—GLUL—Neuronal System—HRAS—peripheral nervous system neoplasm	0.000205	0.000721	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000198	0.000697	CbGpPWpGaD
L-Glutamine—SLC16A10—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000194	0.000684	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—ERBB2—peripheral nervous system neoplasm	0.000192	0.000678	CbGpPWpGaD
L-Glutamine—F13A1—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000185	0.000652	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—MYC—peripheral nervous system neoplasm	0.000184	0.000647	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—GNAS—peripheral nervous system neoplasm	0.000168	0.000594	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—GNAS—peripheral nervous system neoplasm	0.000168	0.000594	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—NRAS—peripheral nervous system neoplasm	0.000167	0.00059	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000165	0.000582	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000165	0.000582	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—NRAS—peripheral nervous system neoplasm	0.000165	0.00058	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—MYC—peripheral nervous system neoplasm	0.000156	0.00055	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—NRAS—peripheral nervous system neoplasm	0.000146	0.000516	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—MYC—peripheral nervous system neoplasm	0.000136	0.00048	CbGpPWpGaD
L-Glutamine—QARS—Gene Expression—AKT1—peripheral nervous system neoplasm	0.000127	0.000449	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—TP53—peripheral nervous system neoplasm	0.000126	0.000444	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—HRAS—peripheral nervous system neoplasm	0.000123	0.000432	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—HRAS—peripheral nervous system neoplasm	0.00012	0.000424	CbGpPWpGaD
L-Glutamine—CTPS1—Metabolism—AKT1—peripheral nervous system neoplasm	0.000111	0.000392	CbGpPWpGaD
L-Glutamine—NADSYN1—Disease—AKT1—peripheral nervous system neoplasm	0.000108	0.000381	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—HRAS—peripheral nervous system neoplasm	0.000107	0.000377	CbGpPWpGaD
L-Glutamine—SLC7A8—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000106	0.000375	CbGpPWpGaD
L-Glutamine—GMPS—Metabolism—AKT1—peripheral nervous system neoplasm	9.9e-05	0.000349	CbGpPWpGaD
L-Glutamine—PFAS—Metabolism—AKT1—peripheral nervous system neoplasm	9.9e-05	0.000349	CbGpPWpGaD
L-Glutamine—CCBL1—Disease—AKT1—peripheral nervous system neoplasm	9.45e-05	0.000333	CbGpPWpGaD
L-Glutamine—NADSYN1—Metabolism—AKT1—peripheral nervous system neoplasm	9.06e-05	0.000319	CbGpPWpGaD
L-Glutamine—GLS2—Metabolism—AKT1—peripheral nervous system neoplasm	7.92e-05	0.000279	CbGpPWpGaD
L-Glutamine—CCBL1—Metabolism—AKT1—peripheral nervous system neoplasm	7.92e-05	0.000279	CbGpPWpGaD
L-Glutamine—GLS—Metabolism—AKT1—peripheral nervous system neoplasm	7.92e-05	0.000279	CbGpPWpGaD
L-Glutamine—CAD—Metabolism—AKT1—peripheral nervous system neoplasm	6.38e-05	0.000225	CbGpPWpGaD
L-Glutamine—PPAT—Metabolism—AKT1—peripheral nervous system neoplasm	5.84e-05	0.000206	CbGpPWpGaD
L-Glutamine—ASNS—Metabolism—AKT1—peripheral nervous system neoplasm	4.55e-05	0.00016	CbGpPWpGaD
L-Glutamine—GLUL—Metabolism—AKT1—peripheral nervous system neoplasm	4.55e-05	0.00016	CbGpPWpGaD
